DK0476849T3 - Human-cytosolphospholipase A2 - Google Patents

Human-cytosolphospholipase A2

Info

Publication number
DK0476849T3
DK0476849T3 DK91307746.7T DK91307746T DK0476849T3 DK 0476849 T3 DK0476849 T3 DK 0476849T3 DK 91307746 T DK91307746 T DK 91307746T DK 0476849 T3 DK0476849 T3 DK 0476849T3
Authority
DK
Denmark
Prior art keywords
novel
phospholipase
pla2
human
human cytosol
Prior art date
Application number
DK91307746.7T
Other languages
English (en)
Inventor
Ruth Maria Kramer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0476849T3 publication Critical patent/DK0476849T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/918—Carboxylic ester hydrolases (3.1.1)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Detergent Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91307746.7T 1990-08-24 1991-08-22 Human-cytosolphospholipase A2 DK0476849T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57351390A 1990-08-24 1990-08-24

Publications (1)

Publication Number Publication Date
DK0476849T3 true DK0476849T3 (da) 1997-07-28

Family

ID=24292288

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91307746.7T DK0476849T3 (da) 1990-08-24 1991-08-22 Human-cytosolphospholipase A2

Country Status (12)

Country Link
EP (1) EP0476849B1 (da)
JP (1) JPH0829080B2 (da)
AT (1) ATE149567T1 (da)
AU (1) AU643061B2 (da)
CA (1) CA2049482A1 (da)
DE (1) DE69124893T2 (da)
DK (1) DK0476849T3 (da)
ES (1) ES2098326T3 (da)
GR (1) GR3023061T3 (da)
HU (1) HUT61588A (da)
IE (1) IE912994A1 (da)
IL (1) IL99227A (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453443A (en) * 1994-07-20 1995-09-26 Merck Frosst Canada, Inc. Bis(aryloxy)alkanes as inhibitors of phospholipase A2 enzymes
CA2365973A1 (en) 1999-03-09 2000-09-14 Laxdale Limited Diagnostic test
KR20040001144A (ko) * 2002-06-27 2004-01-07 김대경 신규한 적혈구 세포질형 포스포리파아제 에이 투 효소,그에 대한 항체, 이들의 용도 및 제조 방법
WO2004081230A1 (ja) * 2003-03-13 2004-09-23 Nippon Soda Co. Ltd. 生理的な活性型構造機能を反映する機能因子の活性評価方法およびその使用
CN103338636A (zh) * 2010-12-07 2013-10-02 好时公司 影响脂肪酸摄取和代谢及炎性介质产生的化合物和从可可产品中分离所述化合物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6443193A (en) * 1987-08-11 1989-02-15 Tanpaku Kogaku Kenkyusho Kk Production of phospholipase a2
JPH03503843A (ja) * 1988-04-15 1991-08-29 バイオジェン インコーポレイテッド ホスホリパーゼa2の精製方法およびホスホリパーゼa2様ポリペプチドの製造方法
IL101507A0 (en) * 1991-04-17 1992-12-30 Lilly Co Eli Compounds,vectors and methods for expressing human,cytosolic phospholipase a2

Also Published As

Publication number Publication date
JPH0829080B2 (ja) 1996-03-27
EP0476849B1 (en) 1997-03-05
IE912994A1 (en) 1992-02-26
IL99227A (en) 1996-10-16
AU8269891A (en) 1993-04-08
JPH0591874A (ja) 1993-04-16
DE69124893D1 (de) 1997-04-10
HU912779D0 (en) 1992-01-28
CA2049482A1 (en) 1992-02-25
DE69124893T2 (de) 1997-09-11
EP0476849A2 (en) 1992-03-25
HUT61588A (en) 1993-01-28
ES2098326T3 (es) 1997-05-01
AU643061B2 (en) 1993-11-04
EP0476849A3 (en) 1992-06-17
ATE149567T1 (de) 1997-03-15
IL99227A0 (en) 1992-07-15
GR3023061T3 (en) 1997-07-30

Similar Documents

Publication Publication Date Title
DK0794961T3 (da) LHRH-antagonistpeptider
HUP0100949A2 (hu) Aril kondenzált azapoliciklusos vegyületek és ezeket tartalmazó gyógyászati készítmények
DK366889A (da) Peptidderivat
NO952869D0 (no) Aminosyrederivater, medikamenter inneholdende disse forbindelser og fremgangsmåter for fremstilling derav
CA1264740C (en) Tetrapyrrole therapeutic agents
ES2153671T3 (es) Peptidos neuroactivos.
ATE331037T1 (de) Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff
RU1833372C (ru) Cпocoб пoлучehия пpoизboдhыx 2,4,5-зameщehhыx бehзoлa
DK0411733T3 (da) 11-beta-aryl-gona-4,9-dien-3-oner
EP1452540A3 (en) Molecular sequence of swine retrovirus and methods of use
AU1634388A (en) Cyclic anticoagulant peptides
AU1634288A (en) Cyclic anticoagulant peptides
AU5901490A (en) Hemoregulatory peptides
ATE149567T1 (de) Menschliche zytosolische phospholipase a2
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
EA199800102A1 (ru) Получение производных бициклогексана
ATE41773T1 (de) 4,5-dihydro-4-oxo-2((2-transphenylcyclopropyl)amino>-3-furancarbonsaeuren und derivate davon.
DK0403458T3 (da) Hidtil ukendte polypeptider og anvendelse deraf
DK166343C (da) Forbedret piroxicamholdigt laegemiddel
DE69315730D1 (de) Verfahren zur Herstellung von Peptiden und neue Zwischenverbindungen dazu
EA199600048A2 (ru) N,n-диэтил-8,8-дипропил-2-азаспиро[4,5]декан-2-пропанамин дималеат, фармацевтическая композиция на его основе и способ индуцирования иммуномодуляции
DK0468063T3 (da) En-beholder fremgangsmåde til fremstilling af -L-asparatyl-L-phenylalanin-methylester, hydrochlorid